Delivery Order SPE2DB20D9226-SPE2DB20FQ56N

Award Date 8/6/20

Potential Completion Date 8/27/20

Potential Value $11K

Federal Agency

Defense Logistics Agency

Awardee

DMS Pharmaceutical Group Inc. PX72BSBQTKJ3

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Park Ridge, IL 60068, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $10,616.18 firm fixed-price contract is for the supply of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities.

DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive array of pharmaceutical items, from common medications to specialized drugs and medical supplies, to fulfill the diverse medical requirements of Department of Defense healthcare facilities worldwide. This contract does not have a set-aside designation.

Generated 1/9/25, 9:11 AM